Skip to main content

Table 3 Tumor response after treatment

From: Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma

Response

DP group

n = 103

S-1 group

n = 72

p value

CR

29 (28.2%)

18 (25.0%)

 

PR

47 (45.6%)

31 (43.1%)

 

SD

25 (24.3%)

21 (29.1%)

 

PD

2 (1.9%)

2 (2.8%)

 

ORR

76 (73.8%)

49 (68.1%)

0.497

  1. CR complete response, PR partial response, SD stable disease, PD progressive disease, ORR objective response rate